Showing 1 - 2 of 2
Background:Background: Information is lacking on the relative effectiveness and cost effectiveness - in a real-life primary-care setting - of leukotriene receptor antagonists (LTRAs) and long-acting β2 adrenergic receptor agonists (β2 agonists) as add-on therapy for patients whose asthma...
Persistent link: https://www.econbiz.de/10008505442
Background:Background: Information is lacking on the relative effectiveness and cost effectiveness - in a primary-care setting - of leukotriene receptor antagonists (LTRAs) as an alternative to inhaled corticosteroids (ICS) for initial asthma controller therapy. Abstract: Objective:Objective: To...
Persistent link: https://www.econbiz.de/10008505444